Epigenetic Regulation in Overcoming Chemoresistance, Volume 19

Explains how epigenetic agents can enhance the chemotherapy sensitivity of diverse types of cancers. The book provides a comprehensive delineation and the recent development of the scientific studies on the epigenetic regulation in enhancing chemo-sensitivity.

In addition, it discusses several topics such as DNA methyltransferase inhibitors (DNMTi), Histone deacetylases inhibitors (HDACi), Histone lysine demethylases inhibitors (HDMi), Histone lysine methyltransferases inhibitors (HMTi) and drugs regulating the microRNA, long non-coding RNA (lncRNA) or RNA methylation. Finally, recent and future developments of the field of epigenetic regulation are explored.

This is a valuable resource for cancer researchers, clinicians, graduate students and several members of biomedical field who are interested in learning about epigenetic regulation methods to reverse chemo-resistance in cancers.

Features

- Presents detailed diagrams of the mechanisms of epigenetic regulation for easy consult

- Encompasses multiple clinical trial summary diagrams to help readers quickly and clearly get information from clinical trials

- Provides future perspectives in each section to inspire readers to use epigenetic regulation to overcome chemo-resistance